new HIV med called Kaletra
October 2000
Abbott is now marketing a new HIV med called Kaletra.It contains TWO protease inhibitors...lopinavir plus a low dose of ritonavir (Norvir).
Lopinavir is the active antiretroviral in Kaletra.
Ritonavir is only a "booster." It inhibits lopinavir metabolism...resulting in higher and more sustained drug levels.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote